Moderna Announces Dosing of the First Monoclonal Antibody Encoded by mRNA in a Clinical Trial Read more
Isatuximab Phase 3 trial meets primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma Read more
Genentech to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) Read more
Concert Pharma Initiates Phase 1 Single-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia Read more
Phase 3 Trial of Rova-T as Second-line Therapy for Advanced Small-Cell Lung Cancer (TAHOE Study) Halted Read more
CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology Read more